Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Almeida

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Epilepsy Research|August 9, 2012
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension studyAndreas Hufnagel, Elinor Ben-Menachem, Alberto A Gabbai, et al.
Journal of Proteome Research|May 28, 2026
Comprehensive Lipidomic Profiling Reveals Distinct Metabolic Remodeling during Differentiation of Human Monocyte-Derived MacrophagesAlice Bacon, Luis Almeida, Mohan Ghorasaini, et al.
Pharmaceutical Research|December 21, 2021
Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population AnalysisCarolina Ameijeiras Rodríguez, Sara Carolina Henriques, Aymara Sancho-Araiz, et al.
Journal of Clinical Pharmacology|May 30, 2008
Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsyLuis Almeida, Ioana Minciu, Teresa Nunes, et al.
The Journal of Physical Chemistry. B|May 22, 2012
Calorimetric determination of rate constants and enthalpy changes for zero-order reactionsLuis Almeida e Sousa, Anthony E Beezer, Lee D Hansen, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 17, 2017
Development of an elisa for the diagnosis of reactive IgE antibodies anti-therapeutic horse seraSalvatore Giovanni De-Simone, Andre Luis Almeida Souza, Aniesse Silva Aguiar, et al.
Clinical Therapeutics|June 28, 2011
Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group studyTeresa Nunes, José Francisco Rocha, Manuel Vaz-da-Silva, et al.
Materials Science & Engineering. C, Materials for Biological Applications|October 25, 2016
A current overview of materials and strategies for potential use in maxillofacial tissue regenerationHossein E Jazayeri, Mohammadreza Tahriri, Mehdi Razavi, et al.
Drugs in R&D|May 10, 2011
Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453)Manuel Vaz-da-Silva, Teresa Nunes, José F Rocha, et al.
Clinical Therapeutics|December 4, 2013
Etamicastat, a novel dopamine β-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertensionLuis Almeida, Teresa Nunes, Raquel Costa, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Epilepsy Research|August 9, 2012
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension studyAndreas Hufnagel, Elinor Ben-Menachem, Alberto A Gabbai, et al.
Journal of Proteome Research|May 28, 2026
Comprehensive Lipidomic Profiling Reveals Distinct Metabolic Remodeling during Differentiation of Human Monocyte-Derived MacrophagesAlice Bacon, Luis Almeida, Mohan Ghorasaini, et al.
Pharmaceutical Research|December 21, 2021
Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population AnalysisCarolina Ameijeiras Rodríguez, Sara Carolina Henriques, Aymara Sancho-Araiz, et al.
Journal of Clinical Pharmacology|May 30, 2008
Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsyLuis Almeida, Ioana Minciu, Teresa Nunes, et al.
The Journal of Physical Chemistry. B|May 22, 2012
Calorimetric determination of rate constants and enthalpy changes for zero-order reactionsLuis Almeida e Sousa, Anthony E Beezer, Lee D Hansen, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 17, 2017
Development of an elisa for the diagnosis of reactive IgE antibodies anti-therapeutic horse seraSalvatore Giovanni De-Simone, Andre Luis Almeida Souza, Aniesse Silva Aguiar, et al.
Clinical Therapeutics|June 28, 2011
Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group studyTeresa Nunes, José Francisco Rocha, Manuel Vaz-da-Silva, et al.
Materials Science & Engineering. C, Materials for Biological Applications|October 25, 2016
A current overview of materials and strategies for potential use in maxillofacial tissue regenerationHossein E Jazayeri, Mohammadreza Tahriri, Mehdi Razavi, et al.
Drugs in R&D|May 10, 2011
Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453)Manuel Vaz-da-Silva, Teresa Nunes, José F Rocha, et al.
Clinical Therapeutics|December 4, 2013
Etamicastat, a novel dopamine β-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertensionLuis Almeida, Teresa Nunes, Raquel Costa, et al.
Pageof 14